FB102
FB102-401
Phase 1 small_molecule active
Quick answer
FB102 for Vitiligo is a Phase 1 program (small_molecule) at Forte Biosciences with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Forte Biosciences
- Indication
- Vitiligo
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active